Bioprosthetics Market
Bioprosthetics Market Analysis By Type (Allograft, Xenograft, Porcine, Bovine), By Application (Cardiovascular, Plastic Surgeries, Wound Healing) & By Region - Global Market Insights 2023-2033
Analysis of Bioprosthetics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Bioprosthetics Market Outlook (2023-2033)
The global bioprosthetics market size is valued at US$ 5.74 Billion in 2023, and is projected to reach US$ 16.30 Billion by 2033, growing at an impressive Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period from 2023 to 2033.
The main types of bioprosthetics are allograft, xenograft, porcine, and bovine. Global demand for xenografts is predicted to increase at a similar CAGR of 11% from 2023 to 2033. Segment growth can be attributed due to the enumerated advantages of these implants, including their long-term stability, ease of availability of raw materials, higher survival rates, low manufacturing costs, and simplicity of implantation procedures. Their broad applicability in fields such as the creation of 3D-based tailored implants and tissue restoration applications makes them a more suitable option among the available bioprosthetics.
Animal tissue is used to create biological valves. They are made from donated human, pig, cow, or horse tissue. A xenograft is a form of animal tissue. The type that comes from a human heart donation is known as an allograft or homograft. To lessen the need for anti-rejection drugs, the valves are treated.
Porcine heart valve replacements have been successfully performed in humans for more than 30 years. It's interesting to note that a pig's heart resembles a human heart in terms of dimensions, mass, and structure.
Pig valve structural degeneration, also known as porcine heart valves, has been discovered to be increased in young to middle-aged individuals. Within four to seven years of the initial procedure, some of these younger patients required second valve replacement surgery. Patients over 60 years old had the highest success rate for porcine valve replacements.
Researchers showed that using a mechanical valve increased survivorship compared to using a porcine bioprosthetic aortic valve placement (76% vs. 66%) in a major randomised experiment, but there was no meaningful difference for patients who had received mitral valve replacement. In a subsequent, 20-year investigation, the survivorship rates showed little to no variation.
Demand for porcine-based devices is also increasing due to the rising R&D activities performed by various researchers due reduce any adverse allergic effects. Animal or human body parts or tissue are employed in bioprosthetics for medical purposes.
In medicine, replacing a missing body part artificially is referred to as a prosthesis. Most people think of prosthetics as devices that replace an absent limb or leg. Prostheses include prosthetic eyes and teeth in addition to the often-used replacements for bones, arteries, and heart valves. The term 'prosthesis' can also refer to devices such as eyeglasses and hearing aids that enhance the functionality of a body part. The medical speciality of prosthetics is the manufacturing of artificial body parts.
Sales of bioprosthetics are increasing rapidly due to the rising incidence of cardiovascular disorders such as rheumatic heart disease, and peripheral artery & coronary diseases, as well as the associated demand for long-term treatment. Furthermore, the growing geriatric population, which is known for having a higher propensity to acquire degenerative cardiac disorders, is expected to boost bioprosthetics market growth over the projected period.
Report Attributes |
Details |
|
Bioprosthetics Market Size (2023E) |
US$ 5.74 Billion |
|
Forecasted Market Value (2033F) |
US$ 16.3 Billion |
|
Global Market Growth Rate (2023-2033) |
11% CAGR |
|
China Market Growth Rate (2023-2033) |
16% CAGR |
|
Japan Market Growth Rate (2023-2033) |
6% CAGR |
|
Germany Market Growth Rate (2023-2033) |
7.5% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Market Trends are Driving High Demand for Bioprosthetic Implants?
“Development of Hybrid Tissue-engineered Bioprostheses Valves”
The creation of hybrid tissue-engineered bioprostheses, which use non-biodegradable, cultured tissue scaffolds enclosed in an alloy of nickel and titanium as strong and durable replacements for conventional, biodegradable tissue-engineered prosthetics, is the result of scientific advancements. The usage of completely synthetic artificial heart valves, which have been linked to high thrombogenicity and require the administration of anticoagulants to prevent concurrent embolic events, valve obstruction, and bleeding, is also anticipated to be gradually replaced by these developments.
Demand in bioprosthetics market is increasing rapidly as a result of these revolutionary solutions' ability to significantly lower the mortality and morbidity linked to heart valve replacement procedures. Additionally, the optimised tissue treatment procedures currently in use improve the prostheses' robustness and do away with the requirement for long-term medicines typically associated with prosthetics, both of which are raising sales of this vertical.
Furthermore, these tissue-engineered products' associated advantages, such as quicker recovery times and a generally better patient safety profile, are due to the development of hybrid constructs and improved tissue preservation techniques. These advantages result in better patient outcomes, which are predicted to influence both physician and patient preference for these implantable bioprostheses.
Several potential opportunities are generated in the bioprosthetics market due to the medical community's increasing preference for these alternative prostheses. The overall demand for the various prostheses is also predicted to be influenced by the increasing number of aortic and mitral valve replacements, as well as cases of damaged heart valves.
“Rising Preference for Minimally-Invasive Procedures and Introduction of Advanced Bioprosthetic Valves”
Demand for bioprosthetic heart valves is increasing as a result of a consistent shift toward minimally-invasive procedures among patients who are becoming more knowledgeable about their therapeutic alternatives. The demand for bioprosthetic aortic valves is also likely to be accelerated by the introduction of new implants and technological advancements.
- To enhance its use in the treatment of aortic stenosis patients who are at a lower risk for open heart procedures, Edward Lifesciences, for example, received the CE mark for Edwards SAPIEN 3 in November 2019.
Manufacturers have recently developed cutting-edge technologies that are efficient, long-lasting, less intrusive, and hemodynamically improved. These medical implants have several advantages and are surgically inserted into the body to replace defective or badly performing heart valves.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What May Prevent Sales of Bioprosthetics from Rising Faster?
“Risk of Several Infections after Surgeries”
People currently lead far more complex and sophisticated lives as a result of the tremendous evolution of lifestyles. Also connected to improper food and lifestyle choices are developing several heart problems.
An untidy lifestyle causes tissue damage and heart issues which increases the demand in bioprosthetics market. Thus, the market further may be constrained by issues such as the possibility of infections, the need for numerous procedures, incompatibility (tissue rejection), and the risk of uneven skin tone and scarring following operations, among others.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
How are Bioprosthetic Sales Unfolding in the U.S.?
“Increasing Cases of Cardiovascular Diseases”
The demand for bioprosthetic valves in the United States is being driven by the rising prevalence of diseases including diabetes and obesity, rising investments in medical research and development, and the existence of favourable reimbursement schemes.
The prevalence of valvular heart disorders has been steadily increasing in the United States over time, necessitating the use of cardiac treatments such as transcatheter aortic valve replacement (TAVR). This trend is anticipated to continue throughout the forecast period.
- Heart disease is the top cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). Cardiovascular disease claims one life in the United States every 34 seconds.
Thus, as a result, the demand for bioprosthetic heart valves in the nation is increasing rapidly. Additionally, the market for bioprosthetics is rising as a result of ongoing technological developments in the healthcare industry and the rising acceptance of minimally-invasive procedures mainly due to the reduced demand for open-heart surgeries.
What is the Demand Outlook for Bioprosthetics in European Countries?
“Rapidly Rising Number of Minimally-Invasive Surgeries”
Germany, the U.K., and Italy are some of the major marketplaces for the medical sector in the European region due to rising medical tourism in these nations.
The demand for heart bio-implants in Germany is expanding as a result of factors including increased cardiac valve disease prevalence and rising demand for minimally-invasive surgeries such as transcatheter aortic valve replacement (TAVR).
The treatment for valvular heart problems known as transcatheter aortic valve replacement (TAVR) has developed over time into an alternate, minimally-invasive option. Around 18,000 TAVR procedures are carried out each year in 97 facilities in Germany employing around 7 different types of valves and better reimbursement guidelines.
How are Sales of Bioprosthetics Shaping Up in Asian Countries?
“Rapidly Developing Healthcare Systems in Asia”
Longer life is guaranteed by bioprosthetic implants. Due to a higher prevalence of cardiovascular disease in the region, several key manufacturers of bioprosthetic heart valve devices are investigating the untapped growth potential in Asian nations such as China, Japan, India, and South Korea.
Asia is home to many developing nations, and their healthcare systems are rapidly evolving. To give its inhabitants better care, respective governmental organisations are concentrating on developing their healthcare infrastructure. The Asia Pacific bioprosthetics market will expand more quickly as a result of the above-mentioned reasons.
The average lifespan of the Japanese is higher than that of the global population, and the rapidly growing number of the senior population is fueling the sales of bioprosthetic valves in the nation. Also, the working population of the nation is living a very stressful lifestyle, and the overburden of stress is leading to several heart-related disorders, which is again boosting sales growth.
Category-wise Analysis
Why are Cases of Cardiovascular Diseases Increasing Rapidly?
“Poor Dietary Habits and High Consumption of Alcohol & Tobacco”
According to the World Health Organization, cardiovascular disease is the leading cause of mortality globally. The main causes of the rise in cardiovascular disease instances include high salt intake, rising tobacco usage, rising cigarette use, and excessive alcohol use.
Cardiovascular problems are more prevalent because of depression, sedentary behaviour, and poor dietary habits. Thus, the demand for bio-implants is increasing rapidly due to the aforementioned reasons.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Some of the key players in the bioprosthetics market are Aortech International Plc, Braile Biomedica, Inc., CryoLife, Inc., Edwards Lifesciences Corporation, Ethicon, Inc., Humacyte, Inc., JenaValve Technology GmbH, and Labcor Laboratorios Ltd.
Leading companies in the bioprosthetics market are strongly investing in R&D and producing advanced bio-implants as well as they are adopting various organic and inorganic strategies to earn more income.
- Aortic disease-focused cardiac and vascular surgery company CryoLife, Inc. announced in January 2022 that it would change its name and brand to Artivion, Inc. with immediate effect. The company's new name and brand, which are derived from the words "aorta," "innovation," and "vision," reflect its evolution to focus on offering cutting-edge solutions to surgeons who treat patients with aortic diseases.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments Covered in Bioprosthetics Industry Research
-
By Type :
- Allograft
- Xenograft
- Porcine
- Bovine
-
By Application :
- Cardiovascular
- Plastic Surgeries
- Wound Healing
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type launches 5.2.2. Cost of Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as Compared to 2008 Economic analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Type 6.1.4.2. Revenue By Application 6.1.4.3. Revenue By Country 6.1.5. 2022 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018-2022 and Forecast, 2023-2033 7.1. Historical Market Volume (Units) Analysis, 2018-2022 7.2. Current and Future Market Volume (Units) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018–2022 and Forecast, 2023-2033 9.1. Historical Market Value (US$ Mn) Analysis, 2018–2022 9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Types & Services, 2018–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2023-2033 10.3.1. Allograft 10.3.2. Xenograft 10.3.3. Porcine 10.3.4. Bovine 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2018–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2023-2033 11.3.1. Cardiovascular 11.3.2. Plastic Surgeries 11.3.3. Wound Healing 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2018–2022 and Forecast 2023-2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018–2022 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018–2022 and Forecast 2023-2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018–2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018–2022 and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018–2022 and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018–2022 and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018–2022 and Forecast 2023-2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018–2022 and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018–2022 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018–2022 and Forecast 2023-2033 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Type 20.2.2. By Application 20.3. Canada Market Analysis 20.3.1. By Type 20.3.2. By Application 20.4. Mexico Market Analysis 20.4.1. By Type 20.4.2. By Application 20.5. Brazil Market Analysis 20.5.1. By Type 20.5.2. By Application 20.6. U.K. Market Analysis 20.6.1. By Type 20.6.2. By Application 20.7. Germany Market Analysis 20.7.1. By Type 20.7.2. By Application 20.8. France Market Analysis 20.8.1. By Type 20.8.2. By Application 20.9. Italy Market Analysis 20.9.1. By Type 20.9.2. By Application 20.10. Spain Market Analysis 20.10.1. By Type 20.10.2. By Application 20.11. BENELUX Market Analysis 20.11.1. By Type 20.11.2. By Application 20.12. Russia Market Analysis 20.12.1. By Type 20.12.2. By Application 20.13. China Market Analysis 20.13.1. By Type 20.13.2. By Application 20.14. Japan Market Analysis 20.14.1. By Type 20.14.2. By Application 20.15. South Korea Market Analysis 20.15.1. By Type 20.15.2. By Application 20.16. India Market Analysis 20.16.1. By Type 20.16.2. By Application 20.17. ASEAN Market Analysis 20.17.1. By Type 20.17.2. By Application 20.18. Australia Market Analysis 20.18.1. By Type 20.18.2. By Application 20.19. New Zealand Market Analysis 20.19.1. By Type 20.19.2. By Application 20.20. GCC Countries Market Analysis 20.20.1. By Type 20.20.2. By Application 20.21. Turkey Market Analysis 20.21.1. By Type 20.21.2. By Application 20.22. South Africa Market Analysis 20.22.1. By Type 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Aortech International Plc 22.3.1.1. Overview 22.3.1.2. Type Portfolio 22.3.1.3. Profitability by Market Segments (Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Braile Biomedica, Inc. 22.3.2.1. Overview 22.3.2.2. Type Portfolio 22.3.2.3. Profitability by Market Segments (Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. CryoLife, Inc. 22.3.3.1. Overview 22.3.3.2. Type Portfolio 22.3.3.3. Profitability by Market Segments (Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Edwards Lifesciences Corporation 22.3.4.1. Overview 22.3.4.2. Type Portfolio 22.3.4.3. Profitability by Market Segments (Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Ethicon, Inc. 22.3.5.1. Overview 22.3.5.2. Type Portfolio 22.3.5.3. Profitability by Market Segments (Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Humacyte, Inc. 22.3.6.1. Overview 22.3.6.2. Type Portfolio 22.3.6.3. Profitability by Market Segments (Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. JenaValve Technology GmbH 22.3.7.1. Overview 22.3.7.2. Type Portfolio 22.3.7.3. Profitability by Market Segments (Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Labcor Laboratorios Ltd. 22.3.8.1. Overview 22.3.8.2. Type Portfolio 22.3.8.3. Profitability by Market Segments (Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. LeMaitre Vascular, Inc. 22.3.9.1. Overview 22.3.9.2. Type Portfolio 22.3.9.3. Profitability by Market Segments (Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. LifeCell International 22.3.10.1. Overview 22.3.10.2. Type Portfolio 22.3.10.3. Profitability by Market Segments (Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018–2033, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 08: Latin America Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 11: Europe Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 14: South Asia Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 17: East Asia Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 20: Oceania Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2022–2032, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018–2033, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018-2022
Figure 02: Global Market Volume Forecast (in 000' Units), 2023-2033
Figure 03: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 04: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 05: Global Market Value Analysis (US$ Mn), 2018-2022
Figure 06: Global Market Value Forecast (US$ Mn), 2023-2033
Figure 07: Global Market Absolute $ Opportunity, 2023-2033
Figure 08: Global Market Share Analysis (%), By Type, 2023-2033
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2023-2033
Figure 10: Global Market Attractiveness Analysis by Type, 2023-2033
Figure 11: Global Market Share Analysis (%), By Application, 2023-2033
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2023-2033
Figure 13: Global Market Attractiveness Analysis by Application, 2023-2033
Figure 14: Global Market Share Analysis (%), By Region, 2023-2033
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2023-2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023-2033
Figure 17: North America Market Value Share, By Type, 2022 (E)
Figure 18: North America Market Value Share, By Application, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018-2022
Figure 21: North America Market Value Forecast (US$ Mn), 2023-2033
Figure 22: North America Market Attractiveness Analysis by Type, 2023-2033
Figure 23: North America Market Attractiveness Analysis by Application, 2023-2033
Figure 24: North America Market Attractiveness Analysis by Country, 2023-2033
Figure 25: Latin America Market Value Share, By Type, 2022 (E)
Figure 26: Latin America Market Value Share, By Application, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018-2022
Figure 29: Latin America Market Value Forecast (US$ Mn), 2023-2033
Figure 30: Latin America Market Attractiveness Analysis by Type, 2023-2033
Figure 31: Latin America Market Attractiveness Analysis by Application, 2023-2033
Figure 32: Latin America Market Attractiveness Analysis by Country, 2023-2033
Figure 33: Europe Market Value Share, By Type, 2022 (E)
Figure 34: Europe Market Value Share, By Application, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018-2022
Figure 37: Europe Market Value Forecast (US$ Mn), 2023-2033
Figure 38: Europe Market Attractiveness Analysis by Type, 2023-2033
Figure 39: Europe Market Attractiveness Analysis by Application, 2023-2033
Figure 40: Europe Market Attractiveness Analysis by Country, 2023-2033
Figure 41: South Asia Market Value Share, By Type, 2022 (E)
Figure 42: South Asia Market Value Share, By Application, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 45: South Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 46: South Asia Market Attractiveness Analysis by Type, 2023-2033
Figure 47: South Asia Market Attractiveness Analysis by Application, 2023-2033
Figure 48: South Asia Market Attractiveness Analysis by Country, 2023-2033
Figure 49: East Asia Market Value Share, By Type, 2022 (E)
Figure 50: East Asia Market Value Share, By Application, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 53: East Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 54: East Asia Market Attractiveness Analysis by Type, 2023-2033
Figure 55: East Asia Market Attractiveness Analysis by Application, 2023-2033
Figure 56: East Asia Market Attractiveness Analysis by Country, 2023-2033
Figure 57: Oceania Market Value Share, By Type, 2022 (E)
Figure 58: Oceania Market Value Share, By Application, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018-2022
Figure 61: Oceania Market Value Forecast (US$ Mn), 2023-2033
Figure 62: Oceania Market Attractiveness Analysis by Type, 2023-2033
Figure 63: Oceania Market Attractiveness Analysis by Application, 2023-2033
Figure 64: Oceania Market Attractiveness Analysis by Country, 2023-2033
Figure 65: Middle East and Africa Market Value Share, By Type, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By Application, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018-2022
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2023-2033
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2023-2033
Figure 71: Middle East and Africa Market Attractiveness Analysis by Application, 2023-2033
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2023-2033
Figure 73: U. S. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 74: U. S. Market Value Share, By Type, 2022 (E)
Figure 75: U. S. Market Value Share, By Application, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2023 & 2033
Figure 77: Canada Market Value Share, By Type, 2022 (E)
Figure 78: Canada Market Value Share, By Application, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2023 & 2033
Figure 80: Mexico Market Value Share, By Type, 2022 (E)
Figure 81: Mexico Market Value Share, By Application, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2023 & 2033
Figure 83: Brazil Market Value Share, By Type, 2022 (E)
Figure 84: Brazil Market Value Share, By Application, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 86: U. K. Market Value Share, By Type, 2022 (E)
Figure 87: U. K. Market Value Share, By Application, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2023 & 2033
Figure 89: Germany Market Value Share, By Type, 2022 (E)
Figure 90: Germany Market Value Share, By Application, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2023 & 2033
Figure 92: France Market Value Share, By Type, 2022 (E)
Figure 93: France Market Value Share, By Application, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2023 & 2033
Figure 95: Italy Market Value Share, By Type, 2022 (E)
Figure 96: Italy Market Value Share, By Application, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2023 & 2033
Figure 98: Spain Market Value Share, By Type, 2022 (E)
Figure 99: Spain Market Value Share, By Application, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 101: Russia Market Value Share, By Type, 2022 (E)
Figure 102: Russia Market Value Share, By Application, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2023 & 2033
Figure 104: China Market Value Share, By Type, 2022 (E)
Figure 105: China Market Value Share, By Application, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2023 & 2033
Figure 107: Japan Market Value Share, By Type, 2022 (E)
Figure 108: Japan Market Value Share, By Application, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2023 & 2033
Figure 110: South Korea Market Value Share, By Type, 2022 (E)
Figure 111: South Korea Market Value Share, By Application, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2023 & 2033
Figure 113: India Market Value Share, By Type, 2022 (E)
Figure 114: India Market Value Share, By Application, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2023 & 2033
Figure 116: ASEAN Market Value Share, By Type, 2022 (E)
Figure 117: ASEAN Market Value Share, By Application, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 119: Australia Market Value Share, By Type, 2022 (E)
Figure 120: Australia Market Value Share, By Application, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2023 & 2033
Figure 122: New Zealand Market Value Share, By Type, 2022 (E)
Figure 123: New Zealand Market Value Share, By Application, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2023 & 2033
Figure 125: GCC Countries Market Value Share, By Type, 2022 (E)
Figure 126: GCC Countries Market Value Share, By Application, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2023 & 2033
Figure 128: Turkey Market Value Share, By Type, 2022 (E)
Figure 129: Turkey Market Value Share, By Application, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2023 & 2033
Figure 131: South Africa Market Value Share, By Type, 2022 (E)
Figure 132: South Africa Market Value Share, By Application, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the bioprosthetics market?
The bioprosthetics market is currently valued at US$ 5.74 billion and is projected to reach US$ 16.3 billion by 2033.
What is the estimated bioprosthetics market growth?
Global demand for bioprosthetics is expected to increase at a CAGR of 11% from 2023 to 2033.
Which are the most profitable regional markets for bioprosthetics?
North America and Europe are dominating markets for manufacturers of bioprosthetics.
Which diseases are majorly driving the sales of bio-implants?
Rising cases of cardiovascular disorders are boosting bioprosthetics market growth.
Who are the top 3 leading companies in this space?
Top providers of bioprosthetics are Braile Biomedica, Inc., CryoLife, Inc., and Edwards Lifesciences Corporation.
Bioprosthetics Market